Bisphosphonate-based strategies for bone tissue engineering and orthopedic implants

Tissue Eng Part B Rev. 2012 Oct;18(5):323-40. doi: 10.1089/ten.TEB.2011.0737. Epub 2012 May 14.

Abstract

Bisphosphonates (BPs) are a group of well-established drugs that are applied in the development of metabolic bone disorder-related therapies. There is increasing interest also in the application of BPs in the context of bone tissue engineering, which is the topic of this review, in which an extensive overview of published studies on the development and applications of BPs-based strategies for bone regeneration is provided with special focus on the rationale for the use of different BPs in three-dimensional (3D) bone tissue scaffolds. The different alternatives that are investigated to address the delivery and sustained release of these therapeutic drugs in the nearby tissues are comprehensively discussed, and the most significant published approaches on bisphosphonate-conjugated drugs in multifunctional 3D scaffolds as well as the role of BPs within coatings for the improved fixation of orthopedic implants are presented and critically evaluated. Finally, the authors' views regarding the remaining challenges in the fields and directions for future research efforts are highlighted.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Bone and Bones*
  • Diphosphonates / administration & dosage*
  • Humans
  • Prostheses and Implants*
  • Tissue Engineering*
  • Tissue Scaffolds

Substances

  • Diphosphonates